Global Bio-Manufacturing Market 2020-2025: Cell Line Engineering, Disposable Manufacturing Technology, Perfusion Culture, In-Silico Modelling, Modular Factories Gaining Momentum


Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Bio-Manufacturing Market By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Others), By Source, By Method, By Equipment, By Type, By Technology, By Application,By End User, By Region, Competition, Forecast & Opportunities, 2025" report has been added to's offering.

The Global Bio-manufacturing Market is expected to grow at a robust pace over the next five years, driven by the rising prevalence of various chronic diseases such as diabetes, cancer, among others. This has been significantly augmenting the demand for effective and faster treatment of these diseases, which in turn is expected to positively influence the bio-manufacturing market. Additionally, increase in the approvals of biologics is further expected to propel the market during forecast period.

Furthermore, increasing expenditure by various governments and major market players and adoption of advanced biomanufacturing strategies to increase the development pipeline of drugs, vaccines, enzymes, among others is expected to foster the market growth through 2025. However, the associated risk of product contamination can hamper the market growth. Also, strict regulatory framework regarding GMP can impede the market growth over next few years.

The monoclonal antibodies segment is expected to dominate the market over the next five years. Additionally, various monoclonal antibodies such as Humira, Remicade, Enbrel, Rituxan, Avastin and Herceptin are available in the market since 2015 which were manufactured using bio-manufacturing process and are doing very well in the market. Also, various monoclonal antibodies are in BLA or equivalent stages thereby driving the growth of the segment.

Based on technology, the market can be categorized into downstream processing, upstream processing, integrated and single use. The single use segment is expected to witness significant growth on account of the associated benefits such as reduced risk of contamination, higher flexibility in multiproduct facilities, cost-effectiveness, among others. Based on end-user, the market can be segmented into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs and others. The CMOs are expected to dominate the market through 2025 due to anticipated increase in the demand for clinical and commercial supply of biologics.

Among all the regions, Asia Pacific is expected to witness significant growth in its bio-manufacturing market owing to the increasing healthcare expenditure by the government and various public-private players, especially in countries like China and India. This has allowed a lot of domestic pharmaceutical companies in these countries to develop a range of biologic products such as monoclonal antibodies, recombinant proteins, among others. Additionally, most of the major players operating in the market are expanding in Asia Pacific due to availability of low cost labor as well as manufacturing facilities, thereby creating lucrative opportunities.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bio-Manufacturing Market

4. Executive Summary

5. Voice of Customer

6. Global Bio-Manufacturing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
6.2.4. By Equipment (Plastic v/s Steel)
6.2.5. By Type (Reusable, Disposable, Automated, Manual)
6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
6.2.7. By Application (Diagnostics v/s Therapeutics)
6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
6.2.9. By Company (2019)
6.2.10. By Region
6.3. Product Market Map

7. Asia-Pacific Bio-Manufacturing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.3. Asia-Pacific: Country Analysis
7.3.1. China Bio-Manufacturing Market Outlook
7.3.2. India Bio-Manufacturing Market Outlook
7.3.3. Australia Bio-Manufacturing Market Outlook
7.3.4. Japan Bio-Manufacturing Market Outlook
7.3.5. South Korea Bio-Manufacturing Market Outlook

8. Europe Bio-Manufacturing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.3. Europe: Country Analysis
8.3.1. France Bio-Manufacturing Market Outlook
8.3.2. Germany Bio-Manufacturing Market Outlook
8.3.3. United Kingdom Bio-Manufacturing Market Outlook
8.3.4. Italy Bio-Manufacturing Market Outlook
8.3.5. Spain Bio-Manufacturing Market Outlook

9. North America Bio-Manufacturing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.3. North America: Country Analysis
9.3.1. United States Bio-Manufacturing Market Outlook
9.3.2. Mexico Bio-Manufacturing Market Outlook
9.3.3. Canada Bio-Manufacturing Market Outlook

10. South America Bio-Manufacturing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.3. South America: Country Analysis
10.3.1. Brazil Bio-Manufacturing Market Outlook
10.3.2. Argentina Bio-Manufacturing Market Outlook
10.3.3. Colombia Bio-Manufacturing Market Outlook

11. Middle East and Africa Bio-Manufacturing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.3. MEA: Country Analysis
11.3.1. South Africa Bio-Manufacturing Market Outlook
11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
11.3.3. UAE Bio-Manufacturing Market Outlook
11.3.4. Kuwait Bio-Manufacturing Market Outlook

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments
13.1. Cell Line Engineering
13.2. Disposable Manufacturing Technology
13.3. Perfusion Culture
13.4. In-Silico Modelling
13.5. Modular Factories

14. Patent Analysis

15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.3. Company Details
15.4. Financials (As Reported)
15.5. Supply/ Value Chain Analysis
15.6. SWOT Analysis
15.7. Key Market Focus and Geographical Presence
15.8. Planned Investments
15.9. Market Positioning
15.10. Import Export Analysis (By Region)
15.11. Pricing Analysis (By Country)
15.12. Leading Players Profiled

  • Abbott Laboratories
  • Abzena Ltd.
  • AGC Biologics GmbH
  • Althea Inc.
  • Amgen Inc.
  • Asymchem Laboratories Inc.
  • Baxter Biopharma Solutions LLC
  • Biocon Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Danaher Corporation
  • Fujifilm Diosynth Biotechnologies
  • Gilead Sciences, Inc
  • Lonza Group
  • MicroProtein Technologies, Inc.
  • Novo Nordisk
  • Patheon N.V. (Thermo Fischer Scientific)
  • Proteogenix Inc.
  • Proteus Digital Health Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.